These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16713033)

  • 1. Multigenotype HCV-NS3 recombinant vaccinia viruses as a model for evaluation of cross-genotype immunity induced by HCV vaccines in the mouse.
    Eisenbach C; Freyse A; Lupu CM; Weigand K; Ernst E; Hoyler B; Stremmel W; Bugert JJ; Encke J
    Vaccine; 2006 Jun; 24(24):5140-8. PubMed ID: 16713033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel hepatitis C virus vaccine approach using recombinant Bacillus Calmette-Guerin expressing multi-epitope antigen.
    Wei SH; Yin W; An QX; Lei YF; Hu XB; Yang J; Lu X; Zhang H; Xu ZK
    Arch Virol; 2008; 153(6):1021-9. PubMed ID: 18421415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations.
    Gordon EJ; Bhat R; Liu Q; Wang YF; Tackney C; Prince AM
    J Infect Dis; 2000 Jan; 181(1):42-50. PubMed ID: 10608749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
    El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
    J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses against HCV-NS3 after accidental infection with HCV-NS3 recombinant vaccinia virus.
    Eisenbach C; Neumann-Haefelin C; Freyse A; Korsukéwitz T; Hoyler B; Stremmel W; Thimme R; Encke J
    J Viral Hepat; 2007 Nov; 14(11):817-9. PubMed ID: 17927619
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
    Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV-NS3 Th1 minigene vaccine based on invariant chain CLIP genetic substitution enhances CD4(+) Th1 cell responses in vivo.
    Gao M; Wang HP; Wang YN; Zhou Y; Wang QL
    Vaccine; 2006 Jun; 24(26):5491-7. PubMed ID: 16725235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.
    Encke J; Radunz W; Eisenbach C; Geib J; Gehrke S; Pfaff E; Stremmel W
    Eur J Clin Invest; 2007 May; 37(5):396-406. PubMed ID: 17461986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity.
    Yusim K; Fischer W; Yoon H; Thurmond J; Fenimore PW; Lauer G; Korber B; Kuiken C
    J Gen Virol; 2010 May; 91(Pt 5):1194-206. PubMed ID: 20053820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus.
    Arribillaga L; Sarobe P; Arina A; Gorraiz M; Borrás-Cuesta F; Ruiz J; Prieto J; Chen L; Melero I; Lasarte JJ
    Vaccine; 2005 May; 23(27):3493-9. PubMed ID: 15855007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.
    Pancholi P; Liu Q; Tricoche N; Zhang P; Perkus ME; Prince AM
    J Infect Dis; 2000 Jul; 182(1):18-27. PubMed ID: 10882577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.
    Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2007 Feb; 25(10):1701-11. PubMed ID: 17240490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model.
    Wedemeyer H; Gagneten S; Davis A; Bartenschlager R; Feinstone S; Rehermann B
    Gastroenterology; 2001 Nov; 121(5):1158-66. PubMed ID: 11677208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.
    Haller AA; Lauer GM; King TH; Kemmler C; Fiolkoski V; Lu Y; Bellgrau D; Rodell TC; Apelian D; Franzusoff A; Duke RC
    Vaccine; 2007 Feb; 25(8):1452-63. PubMed ID: 17098335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation.
    Mello IM; Thumann C; Schvoerer E; Soulier E; Pinho JR; Silvestre DA; Queiroz AT; Wolf P; Baumert TF; Keller FS; Pereira CA
    J Viral Hepat; 2009 Oct; 16(10):732-7. PubMed ID: 19486468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with a recombinant fowlpox virus expressing a hepatitis C virus core-E1 polyprotein variant, protects mice and African green monkeys (Chlorocebus aethiops sabaeus) against challenge with a surrogate vaccinia virus.
    Alvarez-Lajonchere L; Amador-Cañizares Y; Frías R; Milian Y; Musacchio A; Guerra I; Acosta-Rivero N; Martínez G; Castro J; Puentes P; Cosme K; Dueñas-Carrera S
    Biotechnol Appl Biochem; 2008 Oct; 51(Pt 2):97-105. PubMed ID: 18215116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic heterogeneity of the NS3 protease gene in hepatitis C virus genotype 1 from untreated infected patients.
    Vallet S; Gouriou S; Nousbaum JB; Legrand-Quillien MC; Goudeau A; Picard B
    J Med Virol; 2005 Apr; 75(4):528-37. PubMed ID: 15714495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adenoviral vector expressing HCV NS4 induces protective immune responses in a mouse model of Vaccinia-HCV virus infection: a dose and route conundrum.
    Singh S; Vedi S; Li W; Samrat SK; Kumar R; Agrawal B
    Vaccine; 2014 May; 32(23):2712-21. PubMed ID: 24631092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.